Sep 17, 2025 08:32AM New York Medicaid expands TMS therapy coverage for depression treatment

Aug 6, 2025 06:51AM Neuronetics (STIM) PT Lowered to $7 at Canaccord Genuity

Aug 5, 2025 07:15AM Neuronetics (STIM) Misses Q2 EPS by 7c ; Offers Guidance

Jul 28, 2025 04:32AM Citizens JMP Reiterates Market Outperform Rating on Neuronetics (STIM)

Jun 13, 2025 08:26AM Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names

Jun 2, 2025 04:31PM Neuronetics Inc. (STIM) to Join Russell 2000 and Russell 3000 Indexes

May 6, 2025 07:12AM Neuronetics (STIM) Misses Q1 EPS by 2c ; Offers Guidance

Apr 30, 2025 11:20AM North Carolina Passes House Bill 152, Mandates Health benefit Plans must cover TMS

Mar 5, 2025 05:42AM Citizens JMP Reiterates Market Outperform Rating on Neuronetics (STIM)

Mar 4, 2025 05:51PM Neuronetics (STIM) PT Raised to $8 at Canaccord Genuity

Mar 4, 2025 07:17AM Neuronetics (STIM) Misses Q4 EPS by 9c ; Offers Guidance

Feb 7, 2025 07:55AM Neuronetics Inc. (STIM) Prices 8M Share Offering at $2.25/sh

Feb 6, 2025 04:24PM Neuronetics (STIM) Announces Launch of Underwritten Public Offering of Common Stock

Jan 13, 2025 08:03AM Neuronetics Inc. (STIM) Provides Business Update and Issues 2025 Guidance

Nov 12, 2024 07:13AM Neuronetics (STIM) Misses Q3 EPS by 21c; offers guidance

Oct 14, 2024 08:34AM Neuronetics (STIM) Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression

Aug 13, 2024 07:00AM William Blair Downgrades Neuronetics (STIM) to Market Perform

Aug 13, 2024 06:23AM Neuronetics (STIM) PT Lowered to $3 at Canaccord Genuity

Aug 12, 2024 07:15AM Neuronetics (STIM) and Greenbrook TMS Announce Definitive Agreement to Merge

Aug 12, 2024 07:13AM Neuronetics (STIM) Misses Q2 EPS by 6c ; Offers Guidance